Consolidated Statements of Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
Apr. 01, 2018	Dec. 27, 2020	Dec. 29, 2019	Dec. 30, 2018
Income tax expense (benefit)		$ 14,748	$ (611)	$ 2,624
Accumulated other comprehensive income (loss)		(14,168)	(10,185)	(3,143)
Unrealized foreign currency translation gains (losses)		(3,793)	(5,598)	(6,859)
Net unrealized gain (loss) on the interest rate swap agreements		(10,375)	(4,587)	3,716
Adjustment \| ASU 2018-02
Income tax expense (benefit)	$ 455
Joint ventures
Net income (loss) allocated to the redeemable noncontrolling interest from joint venture arrangements		$ 824	$ (519)	$ (488)

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details